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mtcPTM - a database of phosphorylated proteins <p>mtcPTM is a new database of phosphorylated protein sequences and atomic models. Analysis of the phosphosites in mtcPTM showed  that phosphorylation sites are found in a highly heterogeneous range of structural and sequence contexts.</p>
Abstract
mtcPTM is an online repository of human and mouse phosphosites in which data are hierarchically
organized to preserve biologically relevant experimental information, thus allowing straightforward
comparisons of phosphorylation patterns found under different conditions. The database also contains the
largest available collection of atomic models of phosphorylatable proteins. Detailed analysis of this
structural dataset reveals that phosphorylation sites are found in a heterogeneous range of structural and
sequence contexts. mtcPTM is available on the web http://www.mitocheck.org/cgi-bin/mtcPTM/search.
Rationale
In recent years, several sequencing projects have revealed the
complete transcriptomes and proteomes for a number of
organisms, including human [1,2]. The current challenge is to
place this information within the dynamic context of the cell
in order to elucidate how individual molecules interact to
achieve the complex behavior of cellular processes, which
translates into the ability of living organisms to adapt and
thrive in a myriad of environments and conditions. Thus,
much effort has been invested in identifying, for example, the
transcription patterns of genes and the interacting partners of
proteins in order to determine the connections that establish
the intricate cellular pathways [3,4]. To understand these net-
works fully, however, we must also comprehend how their
connections are regulated when the states of individual com-
ponents are altered, for example by means of post-transla-
tional modifications (PTMs). It is therefore crucial to identify
which proteins can be modified as well as the effect and life-
time of the PTMs.
Among PTMs, reversible protein phosphorylation is known to
play a key role in regulating a variety of processes in eukaryo-
tes, from the cell division cycle to neuronal plasticity [5,6].
The most commonly observed phosphorylations affect serine,
threonine, and tyrosine residues [7,8], although phosphoryla-
tion of histidines and aspartates has also been reported (for
review [9]). Protein phosphorylation is catalyzed by enzymes
called protein kinases, which are usually specific for either
tyrosine or serine/threonine, with few of them being able to
modify all three residues indistinguishably [10-12]. The
human genome encodes 518 protein kinases [13,14], and
recent estimates suggest that around one-third of cellular
proteins could undergo phosphorylation [15]. Despite the
progress made during the past few decades, our knowledge
about regulation of protein function by phosphorylation and
the basis of kinase specificity remains incomplete, mainly
because of lack of data. High-throughput proteomic
approaches are expected to help fill this gap because they can
identify large amounts of in vivo modified peptides (for
review [16,17]).
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Protein kinases catalyze the formation of a covalent bond
between a phosphate group and a hydroxyl moiety of an
amino-acid side chain. Because of the size and charge of the
phosphate groups, their introduction could have a local, and
potentially global, effect on the modified proteins. This effect
may translate into modulation of protein activity, subcellular
localization, half-life, and ability to interact with other mole-
cules [8,11]. Undoubtedly, the best characterized examples of
the molecular effects of phosphorylation on proteins are from
high-resolution structural studies (for review [18-20]). For
example, some modifications that affect residues that are part
of or in the vicinity of catalytic sites and protein docking inter-
faces may promote or disrupt substrate binding by a combi-
nation of steric and electrostatic effects, without apparent
major local structural rearrangements Histidine-containing
phosphocarrier protein (HPr) [21], isocitrate dehydrogenase
[22], signal transducer and activator of transcription
[STAT]3B [23], STAT-1 [24], and Stage II sporulation protein
(SpoII)AA/SpoIIAB [25]). On the other hand, the modifica-
tions could cause conformational changes that result either
disorder-to-order transitions (glycogen phosphorylase
[26,27]) or increased local flexibility if the native amino-acid
packing is disrupted (protein kinase A [28,29], mitogen-acti-
vated protein kinase [30], ubiquitin-protein ligase E3 [31],
and potassium channel inactivation domain [32]). However,
because of technical challenges, few atomic structures of pro-
teins are available in their phosphorylated state.
Although atomic models of the proteins in their nonphospho-
rylated form can provide invaluable clues that may enhance
understanding of the molecular impact of modifications on
proteins or allow us to predict them [18], no public resource
is available that routinely stores and provides this informa-
tion. Furthermore, current phosphosite databases only
address the storage and display of phosphosites [33-35], dis-
regarding the experimental context of the phosphorylation.
We have developed the mtcPTM (MitoCheck's post-transla-
tional modifications) database to address these needs. The
m t c P T M  d a t a b a s e  i s  a  r e p o s i t o r y  o f  P T M s  i n  h u m a n  a n d
mouse proteins that aims to preserve and present the experi-
mental evidence that led to the identification of each modifi-
cation. We show that the graphical display of these data
allows intuitive comparisons between phosphorylation pat-
terns from different sources or experiments. The database
also contains structural information on those modified pro-
tein domains for which the actual structure, or the structure
of a close homolog, is available. In addition, we have analyzed
in detail this large structural collection to investigate the
molecular characteristics of phosphorylatable sites in terms
of solvent accessibility, secondary structure preference, and
degree of conservation. We report that, in general, modified
residues are in flexible/exposed regions and, although they
are no more conserved than expected, they present highly
variable degrees of conservation. Finally, we elaborate on
those cases of phosphorylatable residues that were found bur-
ied in the structures, predicting the structural/functional
effect of their modification on these proteins. As part of the
MitoCheck programme, a European Union-funded project
whose overall aim is to study the regulation of mitosis by
phosphorylation [36], mtcPTM was originally developed for
the study of differential phosphorylation in mitosis. However,
its general design is readily applicable to any data, regardless
of experimental source. The database is publicly available
online, and experimentalists are encouraged to submit their
data for storage and display.
Results
Handling and storage of phosphosite data
The mtcPTM database contains data retrieved from litera-
ture, protein annotations, and other databases. In the future,
the database will also display phosphorylation sites that have
been mapped as part of the MitoCheck project. The mtcPTM
database therefore handles quite different datasets, for which
the available information varies. For example, modifications
retrieved from literature and protein annotation are usually
recorded as individual residues, in which experimental infor-
mation can only be recovered by reading the original report.
By contrast, high-throughput mass spectrometry (MS) data
take the form of phosphorylated positions within peptide
sequences. In this case, mtcPTM preserves the experimental
context of the phosphosites by grouping the MS peptides into
sets according to individual experiments and assigning to
each group a hierarchical data structure that summarizes the
experimental information. This simple hierarchy comprises
data source (for instance, a research group or programme),
experimental category (for example, label describing a set of
experiments that are undertaken with a combined aim), and
individual experiments (data obtained from the same sam-
ple). Thus, two experiments undertaken, for example, by
MitoCheck to determine the differential phosphorylation
state of a protein along the cell cycle would receive the follow-
ing common labels: 'MitoCheck', 'timing', and a specific label,
for example interphase or mitosis.
As mentioned above, phosphosites are routinely stored as
positions relative to protein sequences [33-35]. However, this
has the disadvantage that if the protein entry linked to the
phosphosite changes, then the information may be either lost
or transferred incorrectly from one database release to the
next. By contrast, storage of phosphosites as positions rela-
tive to experimentally determined, and thus invariant, pep-
tide sequences allows their automatic update, without
information loss, because the peptides can be matched regu-
larly to the most recent version of the corresponding pro-
teome for each new database release. The ability to update
and keep track automatically of changes in the data between
different releases is important not only to preserve the correct
mapping of the phosphosites but also to take full advantage of
improvements in genome assemblies and gene builds, espe-
cially regarding to the discrimination between splicing vari-
ants and handling of promiscuous peptides found in proteinshttp://genomebiology.com/2007/8/5/R90 Genome Biology 2007,     Volume 8, Issue 5, Article R90       Jiménez et al. R90.3
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Genome Biology 2007, 8:R90
from different genes. This is the strategy followed by the
mtcPTM database. mtcPTM is based on the human and
mouse genomic assemblies defined by Ensembl [37]. Each
time that a new genome assembly or gene build takes place,
all of the peptides stored in mtcPTM are mapped to Ensembl
proteins, recording all peptide-protein and peptide-gene rela-
tionships (see Materials and methods, below). The genomic
mapping of the peptides can be visualized online via the web
interface of the database (Figure 1).
At present, the mtcPTM database stores 13,051 and 7,930
peptides from human and mouse, respectively, correspond-
ing to 13,116 (serine: 9839; threonine: 2067; tyrosine: 1210)
and 8,889 (serine: 6942; threonine: 1470; tyrosine: 477)
phosphorylations. The human-related data comprise 3842
genes and 7753 proteins, whereas for mouse they represent
2721 genes and 3866 proteins.
Display of protein phosphorylation data
The website presents the data for each protein on individual
pages. The tables and graphics in these pages summarize all
known modifications from different experiments, along with
relevant literature and information about the number and
type of sequence and structural domains present in the pro-
tein as well as the frequencies of residues flanking the modi-
fied sites [38]. In particular, the comparison of the
phosphorylation patterns under various conditions is imple-
mented as a graphical display in which the experiments are
grouped, according to the previously mentioned hierarchy,
into different tracks where the raw data, namely (un)modified
peptides, are schematically represented (Figure 2).
The database also contains structural models for proteins and
protein domains that contain modified residues. These mod-
els have been automatically built by homology modeling to
Gene view: display of genomic peptide matches Figure 1
Gene view: display of genomic peptide matches. The figure depicts an example of how genomic matches of peptides from a single experiment are dealt 
with. Gene ENSG00000171467 (top), which has three possible transcripts/proteins (middle), was matched by several peptides obtained from an 
experiment. Of all the three transcripts, ENSP00000354964 was the one containing the highest number of peptides, even though none of them was unique 
for this protein. Therefore, ENSP00000354964 was considered to be part of the minimal list (peptides highlighted in red). However, it may be that the 
peptide patterns could be explained by the presence of the other two transcripts that are not included in the minimal list (peptides in green). However, 
even though more information would be needed to confirm either scenario, the raw data are kept for the users to draw their own conclusions. Peptides 
matching to proteins from other genes are shown at the bottom of the figure. Some of these protein/genes matched additional peptides and therefore they 
were included in the minimal list (red) whereas others did not (green). The latter assignments could thus be considered spurious.R90.4 Genome Biology 2007,     Volume 8, Issue 5, Article R90       Jiménez et al. http://genomebiology.com/2007/8/5/R90
Genome Biology 2007, 8:R90
Figure 2 (see legend on next page)http://genomebiology.com/2007/8/5/R90 Genome Biology 2007,     Volume 8, Issue 5, Article R90       Jiménez et al. R90.5
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Genome Biology 2007, 8:R90
empirically determined atomic co-ordinates. A conservative
criterion for assignment of sequences to structures was used
in order to minimize errors in the modeled domains (see
Materials and methods, below). The coordinates of the mod-
els are provided as RasMol scripts [39], including the pair-
wise alignments between the modeled Ensembl sequences
and its structural templates. The mtcPTM database currently
contains 2,599 structural models, 658 for mouse proteins
(comprising 529 genes), and 1,191 for human (686 genes). On
comparing the phosphosite dataset with these models, only a
small proportion (10% in both human and mouse) of phos-
phosites were found in structurally defined regions. This find-
ing is not expected to be caused by bias resulting from the
type of structural data currently available, because similar
proportions were observed when counting modified positions
within the far more diverse Pfam domains (85% for both
human and mouse proteins fell outside defined Pfam
domains) [40]. This suggested that phosphorylated sites tend
to be found in flexible, unstructured segments and linkers
between domains, which is in agreement with previous obser-
vations [41].
Interestingly, the distribution of residues between linkers and
(structured) domains was not even. Phosphorylated threo-
nine and serine residues were mainly located outside
domains (structures). In mouse, 86% (91%) of serines and
83% (87%) of threonines were found in linkers between
domains (structures), and similar numbers were obtained in
human, specifically 87% (92%) serines and 83% (90%) thre-
onines. However, this distribution was less biased for tyro-
sines, in which 37% (34%) in human and 31% (31%) in mouse
were found within domains (structures). At present, it is
unknown whether these differences between tyrosine and
serine/threonine residues correlate with their propensity to
appear in structured and flexible regions, respectively, or
whether it actually reflects a biologically distinct feature of
their regulation, such as specific properties in kinase recogni-
tion. Of note, the existence of different structural rules for
substrate binding between serine/threonine and tyrosine
protein kinases has previously been suggested [42].
As mentioned previously, atomic information from modified
and unmodified forms of the proteins is invaluable in ration-
alizing the molecular effect and functional impact of phos-
phorylations. Therefore, even though a considerable
proportion of phosphosites is situated away from structured
regions, we wished to take advantage of the large structural
dataset collected here to undertake a detailed study of the
properties of these residues, as well as the potential effect of
their modification on the domains.
Compiling a nonredundant set of structural models
For this analysis, we first defined a nonredundant (NR) set
from all of the structural models stored in the database in
order to preclude potential biases arising from the compari-
sons of highly similar structures (see Materials and methods,
below). The NR set comprised 324 structural models, repre-
senting a wide range of Pfam domains, and contained 264
modified serine/threonine and 219 tyrosine residues. Half of
the models were less than 150 amino acids long, indicating
that half of the models represented single domains and the
other half multidomain structures. Regardless of their length,
the majority of the models (72%) contained only one phos-
phorylated residue. Furthermore, 70% of the models shared
at least 80% sequence identity with their templates and only
15% less than 40%; therefore, the overall quality of the mod-
els is expected to be high.
For the structural analyses, the phosphorylated sites were
clustered into two groups: one composed of serine and threo-
nine residues, the other of tyrosines. This grouping is based
on the similar characteristics of serine and threonine, and the
fact that they are usually targeted by the same protein
kinases. The study focused on the following structural fea-
tures of the phosphosites: relative position within structured
domains, solvent accessibility, secondary structure prefer-
ence, and degree of conservation.
Phosphosites can accumulate at the flanks of 
structured domains
We first investigated the relative locations of phosphosites
within the structures by dividing the length of the domains
into 10 equally long, non-overlapping segments, and then
counting the number of potential and known phosphorylated
residues within each segment. This partitioning normalized
differences in length between the structures. Figure 3 shows
Protein view: graphical comparison of experiments Figure 2 (see previous page)
Protein view: graphical comparison of experiments. The figure shows an example of the graphical display used to present all the phosphosites stored for a 
given protein entry. The protein is represented by a horizontal bar, with the positions of known domains and phosphosites indicated by colored boxes and 
vertical lines, respectively. The top panel depicts a complete summary of all modifications, in which phosphosites are color coded according to whether 
they were fully resolved by the experiment, because sometimes the position of a phosphosite cannot be unambiguously determined by mass spectrometry. 
Thus, confidently determined positions are shown in red, uncertain positions in orange, and positions that have been retrieved from literature or other 
sources and are still awaiting manual curation to confirm their status in gray. The peptide maps for each experiment are then shown underneath, in which 
related experiments are grouped together to allow easy comparison. The color coding is the same as above with the exception that gray is now used to 
highlight residues that have been seen phosphorylated but not in that particular experiment. Further information about individual peptides can be retrieved 
via links from the lines representing them. These peptide pages include details about the sequence of the peptide, experimental data (such as protease and 
software used for their identification), whether the peptide is unique for a gene/protein, its position in the full-length protein, and whether there exist 
sequence variations with respect to the Ensembl sequence.R90.6 Genome Biology 2007,     Volume 8, Issue 5, Article R90       Jiménez et al. http://genomebiology.com/2007/8/5/R90
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that the distribution of potential phosphorylated residues
(any serine/threonine or tyrosine) in the structural models
was nearly constant along the length of their sequences.
Remarkably, this was not the case for known phosphosites.
Phosphorylated serine/threonine residues were over-repre-
sented at both termini (Figure 3a), whereas modified tyro-
sines accumulated towards the amino-terminus and the
middle (Figure 3b). However, this analysis did not take into
account whether the terminal regions corresponded to the
first (or last) structured elements of the structured domains
or to the unstructured tails preceding (or following) them.
The latter could have affected considerably the distributions,
especially in the case of models based on nuclear magnetic
resonance (NMR) structures, in which long flexible termini
are sometimes reported even though they are not an integral
part of the globular cores. Therefore, to account for this, all
terminal residues before (after) the first (last) structured (as
defined by Define Secondary Structure of Proteins [DSSP]
[43]) or buried (as defined by NACCESS [44]) residue of the
amino- (carboxyl-)termini were removed from the models.
Thirty per cent of all serine/threonines and 10% of tyrosines
were found within these tails. After removal of the disordered
termini from the calculations, the distribution of serine/thre-
onines was now closer to that expected by chance (Figure 3a).
Nevertheless, tyrosine residues still seemed to be over-repre-
sented at the amino-terminus of the structured domains (Fig-
ure 3b), where nearly 50% of these terminal tyrosines were
found no more than five amino-acids away from the begin-
ning of the domains (data not shown).
Closer inspection of the examples in which phosphorylated
residues were found in unstructured tails flanking the core
domains allowed us to group them into three different catego-
ries. The first group included termini that, although unstruc-
tured, were an important part of the interface of interaction
with other molecules. Two examples of human proteins
exhibiting this behavior were the Rho GDP-dissociation
inhibitor 2 (ENSP00000228945) and the orphan nuclear
receptor NR4A1 (ENSP00000243050). In the former, the
phosphorylatable amino-terminal residue Y24 [45] was
Phosphosite location relative to the structured domains Figure 3
Phosphosite location relative to the structured domains. The plots show the distributions with the frequencies of occurrences of potential (yellow) and 
known (cyan and red) phosphosites along the length of the structures. The positions correspond to all nonoverlapping and equally long tenths in which the 
sequences can be split, from the amino- (left) to the carboxyl-termini (right). The distributions are shown separately for (a) serine/threonine and (b) 
tyrosine residues. As explained in the main text, the occurrences of known phosphosites were calculated in two different ways: directly from the full-
length structure (cyan) or from trimmed versions of the domains in which disordered and exposed termini had been removed (red).
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found to be tightly packed in the binding interface of the Rho
GDP-dissociation inhibitor 2 with Rac (Figure 4a). In the lat-
ter, the S351 residue [46] was at the unstructured carboxyl-
terminus of the domain participating in DNA-protein interac-
tions (Figure 4b). It is known that phosphorylation of S351 in
the orphan nuclear receptor NR4A1 decreases transcriptional
activity by modulating DNA binding [46], and it is likely that
the phosphorylation state of Rho GDP-dissociation inhibitor
2 will also modulate Rac binding.
The second group contained residues that were in short link-
ers joining adjacent domains. Examples of these are the
human Zinc finger protein 174 (ENSP00000268655) and the
mouse discs large homolog 4 (ENSMUSP00000018700). In
the first example, the phosphorylation [45] can take place
between two zinc-finger motifs (Figure 4c). Modifications tar-
geting the short linkers joining zinc-finger domains were also
found in other proteins (data not shown), and they may regu-
late oligonucleotide binding because the phosphosites are
part of the putative DNA binding interface. In the second
example, a number of phosphosites [47] accumulated
between the PDZ and SH3 domains of the mouse discs large
homolog 4 (Figure 4d), and it is tempting to speculate that the
phosphorylated state of the residues may affect the relative
positioning or allosteric communication between the
domains.
The last group corresponded to those sites located in long and
unstructured termini relatively far away from the domains.
These models were mainly built from NMR structures. For
these cases, it is difficult to predict the effect that the phos-
phorylations could have. However, by analogy to the effect
observed in other examples and considering that disordered
regions appear to play important roles in protein-protein
Phosphosites at unstructured termini Figure 4
Phosphosites at unstructured termini. (a) Structure of the Rho GDP-dissociation inhibitor 2 in complex with RAC [81] (Protein Data Bank [PDB]: 1ds6). 
(b) Structure of the orphan nuclear receptor NR4A1 bound to DNA [82] (PDB: 1cit). In both panels the phosphosite-containing domains are colored in 
cyan and their interacting partners in light yellow. The modified sites are shown in space-filled representation. (c,d) Two examples of phosphorylations 
found in short linkers between domains within the human Zinc finger protein 174 and the mouse discs large homolog 4, respectively. Notice that, for the 
latter, the displayed boundaries of the PDZ domain correspond to those from the structural assignment and not to those defined by Pfam, because the 
latter did not include the carboxyl-terminus. A list with additional details on the examples, including links to the appropriate mtcPTM entries, can be found 
in Additional data file 1.
(a) (b)
(c) (d)
Y24
S351R90.8 Genome Biology 2007,     Volume 8, Issue 5, Article R90       Jiménez et al. http://genomebiology.com/2007/8/5/R90
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recognition events [48], the phosphorylation state of these
sites may regulate the interaction of additional effectors to
these regions, which may be especially important for those in
closer proximity to the structured domains.
Phosphorylatable residues are not always accessible to 
solvent
Next, we wished to assess the accessibility of phosphorylata-
ble residues to solvent and thus to protein kinases. Figure 5
shows the plots with the distributions of the calculated per-
centage of solvent accessibility for the side chains of known
phosphorylated residues as compared with that of all residues
and potential phosphosites (any serine/threonine or tyro-
sine). It is clear that the side chains of phosphorylated resi-
d u e s  t e n d  t o  b e  m o r e  e x p o sed. This trend is specially
pronounced for serine and threonine, which are two relatively
small amino acids, and less so for tyrosine, which probably is
because its large hydrophobic ring is usually at least partly
protected from solvent. These results were not surprising
because phosphorylatable residues would need to fit into the
substrate recognition clefts of protein kinases. Therefore, it
was intriguing to note that nearly 15% of all phosphosites
exhibited less than 10% solvent accessibility of their side
chains in the unmodified form of the protein. These buried
residues would not only have problems acting as substrates
for kinases, but they could also require local amino-acid re-
packing to accommodate the different electrostatic and steric
properties between the unmodified and phosphorylated
states (see below for detailed descriptions of several examples
of buried phosphosites).
Phosphorylated serine/threonines show a marginal 
preference for loops, whereas tyrosines do not
Another question to be addressed was whether phosphor-
ylated residues exhibit any preference for particular
Solvent accessibility of phosphorylatable residues Figure 5
Solvent accessibility of phosphorylatable residues. The plots show the distributions of the percentage of solvent accessibility of the (a) serine/threonine 
and (b) tyrosine side chains in the structures, as calculated by NACCESS [44]. The cyan and red columns correspond to the distributions for all potential 
and known phosphorylated residues, respectively, whereas the yellow columns are controls summarizing the solvent accessibility of all amino acids. 
Exposed terminal regions were not included in the calculations. These distributions were identical to that calculated from the templates or from models 
sharing at least 80% identity to the templates, indicating that, overall, the modeled conformations of the residues holding the phosphosites are expected to 
be accurate.
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structural elements. For this, the number of occurrences of
phosphosites in four types of secondary structure elements
(as defined by DSSP), namely helices, strands, loops and
other, was counted excluding all terminal residues preceding
(following) the first (last) structured amino acid (see above).
The results are summarized in Figure 6. It appeared that
phosphorylated tyrosines did not prefer any particular struc-
tural environment (P = 0.64) when compared with all tyro-
sines (Figure 6b). On the other hand, there was a marginal
preference (P = 0.08) for phosphorylated serine/threonine
residues to be located in disordered regions connecting
strands or helices (Figure 6a).
Phosphosites are not more conserved than expected
Because PTMs can play functional roles, phosphosites would
be expected to be under purifying selection, and thus con-
served through evolution. To investigate this, multiple
sequence alignments were calculated from homologs to the
modeled structures [49], and the conservation of each posi-
tion corresponding to the phosphosites was assessed. The
initial alignments, which can be retrieved via the mtcPTM
web interface, contained nonredundant sequences sharing at
least 30% sequence identity with the model. Although the
inclusion of sequences that were up to 30% identical to the
query domain ensured that they would adopt nearly identical
structural arrangements to it [50], the alignments could
present not only orthologous but also paralogous domains
[51]. For the latter, the phosphorylation patterns may be dif-
ferent or absent because of functional divergence. Further-
more, the alignments may also contain sequences from
distantly related organisms in which the phosphorylation
patterns may have evolved differently. To account for these
potential sources of variability, the degree of conservation of
each phosphosite was assessed for several subdivisions of the
initial alignments. Briefly, conservation scores were calcu-
lated for the full alignments (all sequences at least 30% iden-
tical to the query) and for three subsets containing only
sequences that were at least 40%, 50%, or 60% identical to
the query. In alignments obtained from sequence identity
cut-offs equal to or higher than 40%, most sequences are
expected to be orthologous [51].
The overall trends for the two-amino-acid subgroups (serine/
threonine and tyrosine) were similar, and therefore the two
sets were merged (Figure 7). At a low identity cut-off (>30%)
very few sites were highly conserved (Figure 7a). Only less
than 5% of the sites were strictly conserved across the align-
ments, and not more than 20% of the sites were conserved in
at least 80% of all of the homologs within the alignments. As
expected, the degree of conservation increased with increas-
ing cut-off (Figure 7a to 7d). However, even for domains shar-
ing overall sequence identities of 60% (and thus likely to
contain only orthologs from closely related organisms), a con-
siderable number of sites (about 16%) exhibited
conservations lower than 40% (Figure 7d). Interestingly, in
all subdivisions, the degree of conservation of known phos-
phosites was nearly identical to that from potential, solvent
accessible, phosphosites.
What happens when phosphorylatable sites are buried
As mentioned above, most phosphorylatable sites were con-
siderably exposed to solvent and thus potentially accessible
by protein kinases. However, for a few phosphosites, their
side chains were found to present not only low solvent
accessibility but to be actually packed into the domain core.
Modification of these buried residues is likely to have struc-
tural implications because the intramolecular packing
between the two states may be different. Depending on the
Distribution of phosphosites with respect to secondary structure elements Figure 6
Distribution of phosphosites with respect to secondary structure elements. The plots represent the frequency of occurrences of phosphorylated (a) 
serine/threonine and (b) tyrosine residues in the elements of secondary structure of the models as defined by Dictionary of Protein Secondary Structure 
(DSSP) [43]. The three sets shown as well as their color coding are identical to those from Figure 5.
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amount of atomic interactions involved, the conformational
changes could have local or global effects, from rigid body dis-
placements to partial or total unfolding. In fact, our dataset
contained some examples of proteins that have already been
shown to undergo conformational changes upon
phosphorylation (mitogen-activated protein kinase [30] and
ubiquitin-protein ligase E3 [31]). In both cases the structural
rearrangements are critical for activation of the proteins.
Given the intriguing nature of the buried phosphorylatable
residues, we studied them systematically to elucidate how the
phosphorylation could take place and what its potential struc-
tural impact could be. During the analysis, in order to ensure
that the conformation of the residues of interest was likely to
be native, only models in which the phosphorylatable side
chains had been built based on the same or similar residues
from the templates were considered. We also checked the
consistency of poor solvent accessibility for those residues in
which there existed other available models, with similar
sequence identity to the templates, in the redundant set. We
found 13 examples of this in which ten exhibited similar low
accessibility (at a 10% cut-off) and three examples in which
both the exposed and buried versions could exist, depending
on the conformational states of the proteins. The latter
included the active and auto-inhibitory conformations of
human tyrosine-protein kinase c-Src [52,53]. The other two
examples are discussed below.
The analysis of phosphorylatable buried residues revealed
that their modifications could have three major structural/
functional effects on the structures: regulation of function by
affecting functional sites directly or indirectly; spatial rear-
rangements, presumably by rigid body movements, of
domains within a protein; and opening of the structure, lead-
ing to local flexibility.
Phosphorylation of buried residues found at or close to 
functional sites
Active sites and binding pockets for small/medium-size mol-
ecules are usually inside clefts. Therefore, phosphosites found
around them are likely to be, at least partially, buried. Their
phosphorylation may affect either directly or indirectly the
integrity of the functional sites depending on whether they
are part or in the vicinity of them, respectively. An example of
Evolutionary conservation of phosphorylated sites Figure 7
Evolutionary conservation of phosphorylated sites. The plots show the distribution of the percentage of known (red) or potential (cyan) phosphosites 
presenting a given degree of conservation (between 0 and 20, 20 and 40, and so on) in four sets of multiple alignments. These four sets of multiple 
alignments, which contain different sequence diversity, comprise sequences sharing at least (a) 30%, (b) 40%, (c) 50%, or (d) 60% identity with respect to 
the human or mouse queries.
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the latter can be found in human 5'-deoxy-5'-methylthioade-
nosine phosphorylase (ENSP00000369519), where the bur-
ied phosphosite S183 [54] sits in a peripheral helix that is part
of the binding groove for adenine (Figure 8a). On the other
hand, an example of a phosphorylatable residue [45] that is
actually involved in substrate binding can be seen in human
malate dehydrogenase type 2 (ENSP00000327070), in which
the nonphosphorylated version of the residue Y56 interacts
with the NAD co-factor (Figure 8b).
Phosphorylatable buried residues at or close to functional sites Figure 8
Phosphorylatable buried residues at or close to functional sites. The figure shows examples of phosphorylatable buried residues that are found at or in the 
vicinity of binding sites for small or large molecules. All the structures are shown differentially colored from their amino- (cold colors) to their carboxyl-
termini (hot colors), with the phosphosites in white space-filled representation and their bound substrate in dark gray unless stated otherwise. (a) 
Structure of human 5'-deoxy-5'-methylthioadenosine phosphorylase [83] (Protein Data Bank [PDB]: 1cb0) with an adenine molecule. (b) Structure of 
homodimeric human malate dehydrogenase type 2 bound to NAD co-factor (unpublished data; PDB: 2dfd). (c) Structure of the carboxyl-terminal C2 
domain of human tricalbin modeled onto the C2 domain of phospatidylinositide 3-kinase C2 α [55] (PDB: 2b3r). (d) Structure of a histone dimer (red and 
light yellow) bound to DNA (green and cyan) [84] (PDB: 1kx5). (e) Structure of the homodimer formed by the zinc-finger domains of the estrogen 
receptor in complex with DNA (cyan and blue) [85] (PDB: 1hcq). A list with additional details of the examples, including links to the appropriate mtcPTM 
entries, can be found in Additional data file 2.
(a) (b)
(c) (e) (d)
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It is tempting to hypothesize that phosphorylation of the car-
boxyl-terminal C2 domain of human tricalbin
(ENSP00000267113) could also regulate its substrate-bind-
ing capability. This domain is phosphorylated at position
Y1009 [45], which is located at the concave face of the β-sand-
wich, a region rich in positively charged residues (Figure 8c).
In homologous domains, including the template used for the
modeling [55], this poly-basic region can have phospholipid-
binding capabilities [56]. Therefore, covalent attachment of a
phosphate to this tyrosine would alter the net charge of the
region and thus could affect its putative ability to interact
with lipids. Of note, the equivalent tyrosine (Y822) in another
C2 domain within this protein can also be phosphorylated
[45]. Interestingly, these tyrosines are very conserved across
C2 domains, including distantly related paralogs. However,
phosphorylations at these positions have not been reported
for other well characterized C2 domain subfamilies. There-
fore, phosphorylation of this tyrosine may be an exclusive fea-
ture of some tricalbin C2 domains.
In addition to phosphosites in binding pockets for small sub-
strates, modifications were also found in areas involved in
binding to larger molecules. This was the case for histones
(ENSP00000350159) and the zinc-finger domain of the
human estrogen receptor (ENSP00000343925). In the latter,
the residue that can be phosphorylated, namely S165, is found
at a short loop, which is in direct contact with DNA (Figure
8e). Phosphorylation at S165 is critical for activation of the
transcription factor, perhaps by precluding interactions with
inhibitors that may occlude the DNA-binding interface [57].
In the histone, the phosphorylatable Y52 residue [45] is
packed into one of the two small cores of the histone domain
(Figure 8d). This region is involved in both DNA binding and
interactions with another histone monomer. In this case, the
introduction of phosphate groups may also regulate the DNA-
binding or protein-binding capabilities of the domains.
Phosphorylation of residues buried between domains 
within the same protein
When buried residues are found in hinge regions or at the
interface between domains within the same protein, their
modification could trigger changes, for example, by means of
rigid body rotations or translations, in the relative positioning
between domains in order to accommodate the new cova-
lently attached phosphates. Examples of phosphosites pack-
ing at the interface between domains were found in human
thioredoxin reductase 1 (ENSP00000373506; Figure 9a) and
the α isoform of the human guanine nucleotide dissociation
inhibitor (ENSP00000369538; Figure 9b). On the other
hand, examples of phosphosites at potential hinge regions
between domains were present in mouse Sec1
(ENSMUSP00000052440). Figure 9c shows that its buried,
phosphorylatable residues [47] pack at the interfaces between
domains (Y145, S146, S241, and T248) or at the domain core
(T346). Interestingly, the residues affected are important for
the maintenance of the U-shaped conformation that recog-
nizes syntaxin-1. Therefore, their modification, along with
that of other surface residues [58], may have functional impli-
cations regarding the ability of Sec-1 to bind syntaxin-1. All of
these residues were relatively well conserved except for Y145.
However, the latter was otherwise replaced by phenylalanine,
suggesting that this position does indeed play an important
structural role in domain packing.
The phosphorylation state of buried residues could 
influence the structural conformation of the protein
When buried residues that participate in the packing of the
protein core or of isolated secondary structure elements to the
globular domain can be phosphorylated, their modifications
could lead to structural instability. In the case of isolated ele-
ments of secondary structure, for example those at the
domain termini, this instability may lead to their detachment,
perhaps without compromising the structural integrity of the
core domain. On the other hand, when the modified residues
are part of the hydrophobic core of the domain, the modifica-
tion could cause considerable structural rearrangements,
including local or even total unfolding, if the packing of the
unmodified residue were critical for the maintenance of the
overall structure and no alternative stable packing for its
phosphorylated form could be established.
There were several examples of buried phosphorylatable res-
idues located at terminal structural elements. Three of these
examples have already been proposed to alter the conforma-
tion of the affected proteins. The first example was the human
7508A NBD1 domain (ENSP00000003084), in which the
carboxyl-terminal helix of the first ABC transporter domain
contains a buried serine residue (S660) that can be
phosphorylated [59]. The residue participates in the packing
of the helix to the domain (Figure 10a). The helix and its pre-
ceding loop are rather flexible and their conformational pref-
erence may be altered by phosphorylation of S660 [60]. A
second example was the auto-inhibited human p47phox
(ENSP00000297905), in which the carboxyl-terminal helix
packs to a SH3 domain via a phosphorylatable serine at posi-
tion 331 (Figure 10b) [61]. Additional phosphorylation sites
are found in another buried residue, namely S211 (Figure
10b), as well as several exposed serines (306, 307, 318, and
323) at the loop preceding the carboxyl-terminal helix. Multi-
ple phosphorylations involving these sites have been seen to
unmask the SH3 domain, facilitating interactions with other
proteins that ultimately result in the formation of an active
enzyme complex [62]. It is worth noting that the conforma-
tion of these domains is very different when complexed to a
p22phox-derived peptide [63], where the S211 residue does not
pack intramolecularly. The third example was the structure of
human annexin-1 (ENSP00000257497). This protein has
three buried residues that can potentially be phosphorylated
(Figure 10c): Y21, Y207, and T216. Y21 is found after the first
amino-terminal helix packing against the globular part of the
protein, whereas Y207 and T216 are both part of a peripheral
two-helix bundle. It has been suggested that multisitehttp://genomebiology.com/2007/8/5/R90 Genome Biology 2007,     Volume 8, Issue 5, Article R90       Jiménez et al. R90.13
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phosphorylation of Y21 and neighboring residues (T24, S27,
and S28) (Figure 10c) exposes the amino-terminus, which is
critical for vesicle aggregation [64]. This terminal region is
specific for different annexins and presents intrinsic flexibil-
ity [64]. In the region comprising Y207 and T216, we found
that T216 also packs onto a flexible loop as deduced from its
high temperature factor in the crystal structure and that the
solvent accessibility of Y207 slightly varies in other crystal
structures due to the different conformation of the neighbor-
ing arginine 212 [65]. Furthermore, T207 and T216 are both
surrounded by charged residues, and thus their phosphoryla-
tion could induce electrostatic- and steric-induced
rearrangements.
Additional examples of phosphorylatable buried residues at
terminal regions were found in the regulator of G-protein
signaling 16 and the serine/threonine protein phosphatase
PP1-β catalytic subunit. In the former (ENSP00000356529),
the phosphorylation of Y177 [66], which is found in the car-
boxyl-terminal helix packing tightly against the amino-termi-
nal helix (Figure 10d), may disrupt the interaction between
these two helices. This effect could be reinforced by additional
phosphorylation of Y168, which also packs against the car-
boxyl-terminus of the amino-terminal helix (Figure 10d).
Both tyrosines are well conserved and only occasionally
replaced by phenylalanines, which is indicative of their
important structural roles. In the human serine/threonine
protein phosphatase PP1-β catalytic subunit
(ENSP00000351298), S41 [54] is found in the second amino-
terminal helix (Figure 10e), whose packing to the domain
appears critical in maintaining an optimal arrangement of the
two terminal helices. In the crystal structure, the loop joining
these two helices participates in the binding to a PEG mole-
cule and, to a lesser extent, to the 130 kDa myosin-binding
subunit of smooth muscle myosin phosphatase [67]. Of note,
S41 is only conserved in closely related sequences and is oth-
erwise replaced by small hydrophobic residues that could still
allow the helix to pack against the domain. Figure 9
(a)
Y422
Y333
T346
T248
S241
S14
Y145
(b)
(c)
Phosphorylatable residues buried between domains Figure 9
Phosphorylatable residues buried between domains. The figure shows 
examples of phosphorylated buried residues found in hinge regions or at 
the interface between domains from the same protein. All of the 
structures are shown differentially colored from their amino- (cold colors) 
to their carboxyl-termini (hot colors) and the phosphosites in white 
space-filled representations unless stated otherwise. (a) Structure of 
human thioredoxin reductase 1 (unpublished data; Protein Data Bank 
[PDB]: 2cfy). The residue that can be phosphorylated, Y422, participates in 
the interface between the two domains of the protein, namely the pyridine 
nucleotide-disulphide oxidoreductase (cyan) and the dimerization (red) 
domains. The substrate for the enzyme is shown in yellow. (b) Structure 
of the α isoform of the guanine nucleotide dissociation inhibitor [86] 
(PDB: 1gnd). (c) Structure of mouse Sec1 complexed with syntaxin-1 
(light gray) [58] (PDB: 1dn1). The phosphorylatable residues are shown in 
the same color as the protein backbone to facilitate their localization along 
the structure. A list with additional details of the examples, including links 
to the appropriate mtcPTM entries, can be found in Additional data file 2.R90.14 Genome Biology 2007,     Volume 8, Issue 5, Article R90       Jiménez et al. http://genomebiology.com/2007/8/5/R90
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Figure 10 (see legend on next page)
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There were also examples of buried residues in nonterminal
regions for which their phosphorylation may induce local
structural rearrangements. The first example was the struc-
ture of human DJ-1, a protein that is related to male fertility
and Parkinson's disease (ENSP00000340278) [68]. Y67 is
found in a loop that contributes to the packing of a short helix
against the domain (Figure 10f). This helix is the most disor-
dered region in the electron density of the crystal structure
[69]. Its flexibility could increase upon phosphorylation of
Y67, because the phosphorylated amino acid may preclude its
packing to the domain. This could ultimately affect the pre-
ceding loop, which participates in the dimer interface in the
crystal structure. Interestingly, Y67 is poorly conserved,
although the important role of this position is evident because
the preferred replacement is phenylalanine. The second
example was the human 60S ribosomal protein L7-A
(ENSP00000339795). Here, Y139 packs against a helical
motif on the surface of the protein (Figure 10g). Its phospho-
rylation may affect the conformation of this motif, which is
involved in RNA-protein interactions [70]. Finally, the struc-
ture of the human elongation factor EEF1A was an excellent
example of both potential local conformational
rearrangement and domain re-orientation
(ENSP00000339053). The first involves Y29 (Figure 10h),
which is found packing in the core of a helical subdomain
formed at the amino-terminal elongation factor Tu GTP-
binding domain. The second involves T432 (Figure 10h),
which is packed between two domains, namely elongation
factor Tu GTP-binding domain and elongation factor Tu car-
boxyl-terminal domain, of this multi-domain protein. Phos-
phorylation of T432 may affect the relative orientations
between domains within the protein, whereas Y29 may mod-
ulate the conformation of the helical subdomain. The orienta-
tions of the domains and of the helical bundle are likely to be
critical for an effective interaction of the protein with the cat-
alytical carboxyl-terminal domain of EEF1BA (Figure 10h).
Discussion
We have presented a database, mtcPTM, that stores human
and mouse phosphosites [71]. The database integrates data
from low-throughput and high-throughput screenings and, in
contrast to other, similar databases, it explicitly preserves the
experimental context for each phosphosite by means of a
three-level hierarchy annotation. Furthermore, the phos-
phosites are stored as relative positions within experimen-
tally determined peptides, which allows automatic updates
without loss of information, against new genome assemblies
or gene builds. The data are publicly accessible via a web
interface, in which the user can retrieve the mapping of the
peptides onto the Ensembl genome as well as extensive infor-
mation about the phosphorylated proteins including
graphical comparisons of phosphorylation patterns under
different conditions. At present, only mass spectrometric data
are explicitly referenced to their experimental sources. In the
future, the low-throughput data could be integrated likewise
by, for example, using the relevant literature references to
manually assign the data hierarchy.
Another major asset of the mtcPTM database is that it con-
tains atomic models for a considerable number of
phosphosites. These models have been automatically built by
homology to experimentally determined structures using a
conservative procedure in order to minimize modeling errors.
Although a higher number of structural models could have
been obtained by the use of more sensitive fold recognition
techniques, the use of templates sharing low sequence simi-
larity with the targets may decrease the overall quality of the
models. To our knowledge, the structural set provided here is
the largest freely available collection of phosphorylatable
proteins.
From the study of this large structural collection, some gen-
eral trends have been observed. For example, we find that
some termini or regions close to the termini of structured
domains may be preferentially phosphorylated. These phos-
phosites would be readily accessible by protein kinases, and
their behavior could be similar to those found in the most
frequent case of unstructured regions linking domains. Also,
the degree of conservation of phosphosites varies
considerably from protein to protein not only with respect to
distantly related species and paralogs but also between
closely related organisms. Few cases of highly conserved sites
were found across alignments containing very diverse
Buried residues whose phosphorylation state could affect local structural conformation Figure 10 (see previous page)
Buried residues whose phosphorylation state could affect local structural conformation. The figure shows several examples of buried residues whose 
phosphorylation may result in conformational rearrangements, including detachment of secondary structure elements from the protein domain. Unless 
stated otherwise, all the structures are shown differentially colored from their amino- (cold colors) to their carboxyl-termini (hot colors), with the regions 
whose conformation is predicted to be affected in gray, and the phosphosites in white space-filled representation. (a) Structure of the human 7508A 
NBD1 domain [60] (Protein Data Bank [PDB]: 1xmi). (b) Structure of the autoinhibited p47phox [62] (PDB: 1ng2). (c) Structure of annexin-1 [64] (PDB: 
1hm6). Other residues, namely T24, S27 and S28, that can also be phosphorylated, although they are not buried, are shown in gray. The region encircled 
is likely to be affected by phosphorylation of the enclosed amino acids, as described in the main text. (d) Structure of the regulator of G-protein signaling 
16 (unpublished data; PDB: 2bt2). (e) Structure of the serine/threonine protein phosphatase PP1-β catalytic subunit [67] (PDB: 1s70). A PEG molecule is 
shown in red and the 130 kDa myosin-binding subunit of smooth muscle myosin phosphatase in white. (f) Structure of DJ-1, a protein related to male 
fertility and Parkinson's disease [69] (PDB: 1ps4). (g) Structure of the 60S ribosomal protein L7-A [70] (PDB: 1s1i). (h) Structure of the elongation factor 
EEF1A [87] (PDB: 1f60), in which their individual domains are shown in blue (elongation factor Tu GTP-binding domain), cyan (elongation factor Tu 
domain 2), and green (elongation factor Tu carboxyl-terminal domain). The catalytic carboxyl-terminal domain of EEF1BA is shown in yellow. A list with 
additional details of the examples, including links to mtcPTM entries, can be found in Additional data file 2.R90.16 Genome Biology 2007,     Volume 8, Issue 5, Article R90       Jiménez et al. http://genomebiology.com/2007/8/5/R90
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sequences, and some sites were also poorly conserved even in
alignments of highly similar sequences. Overall, this indicates
that the evolution of phosphosites could be less constrained
than that of other functional motifs, such as catalytic sites.
This variation could be organism-specific for a number of cel-
lular processes or it may reflect the different importance of
phosphorylation as a regulatory strategy between organisms.
Alternatively, the precise position of phosphosites may in
some cases not be critical for its action, especially in proteins
regulated by multisite phosphorylation [8]. Furthermore, we
have also noticed that high conservation does not necessarily
indicate that a given site will be phosphorylated in all
homologs (for example, the C2 domains of tricalbin). Further
studies will be needed to clarify and elaborate on these
observations.
We have also reported that the side chains of phosphorylata-
ble amino acids are usually exposed to solvent. However, we
found a significant number of sites that were buried. It could
be possible that some of these cases were artifactual, caused
by experimental in vitro phosphorylation of non-full-length
constructs, ambiguous peptide-protein assignment, or mode-
ling artefacts. However, in most cases the models were built
from structures that share high similarity to the target
sequences and thus, except in regions with intrinsic high flex-
ibility or poor steric constraints, the conformation of the
modeled side chains are probably nearly native, especially for
conserved buried residues. Also, all instances considered here
in which there was available structural information for a
phosphopeptide matching to different genes (mainly genes
with multiple, highly similar copies such as histones, elonga-
tion factors and ribosomal proteins), the sequences of the
modeled domains were nearly, if not completely, identical
and therefore the equivalent phosphosites presented similar
low solvent accessibility because they were built based on the
same structural templates. Furthermore, some of these bur-
ied phosphosites were either identified under in vivo condi-
tions or have already been empirically characterized in some
detail, suggesting that most buried phosphorylatable residues
reported here are likely to be bona fide phosphosites.
By exploring systematically the examples of phosphorylatable
buried sites, we have been able to predict the functional
impact of the modifications to some proteins and to classify
the residues into three categories according to their predicted
effect. These categories are residues in or close to binding
pockets or intermolecular interfaces; residues at interfaces or
in hinge regions between structural units of multidomain
proteins; and residues whose phosphorylated state is likely to
result in conformational rearrangements, including detach-
ment of secondary structure elements. In the first two cases,
the disturbance of binding sites or interfaces would introduce
steric and electrostatic constraints for intermolecular binding
leading to loss of activity and rigid body rearrangements
between the structural units of the multidomain proteins,
respectively. For the third category, it is tempting to suggest
that isolated elements of secondary structure joined to the
main domain by long disordered, usually loosely packed, link-
ers could be released to solvent upon modification of residues
that pack them against the main domain. This release could
serve to re-orient domains within the protein. Alternatively,
the now flexible fragments or newly exposed areas on the core
domain could play a role in the downstream recruitment of
additional effectors. We have also observed cases in which the
modifications are likely to result in local unfolding/refolding.
However, we have not observed cases in which the modifica-
tion could lead to major unfolding, perhaps because of the
limited size of our dataset or because these modifications are
rare. In any case, it is likely that these modifications could
regulate the half-life of the protein.
How protein kinases could have access to the buried residues
remains to be addressed. However, several possible mecha-
nisms could facilitate kinase accessibility. If residues to be
phosphorylated were in relatively loose or in disordered
structural elements, then this intrinsic flexibility may result
in spontaneous opening of the regions, temporarily exposing
the residues to protein kinases. We have seen examples of
phosphosites sitting in naturally flexible regions as identified
by examining the temperature factor of the crystal structure
templates (also see [72]) or the variability in the ensembles of
various atomic models solved by NMR. However, it must be
remembered that in some cases additional co-factors/effec-
tors may be required to actively extract and present the resi-
dues to the phosphorylating enzymes.
Finally, although this structural study has revealed some gen-
eral features, it has also made it clear that the impact of phos-
phorylations will depend on the atomic environment of the
modified residue and thus is likely to be case specific.
Therefore, we believe that making these structural data pub-
licly available via the mtcPTM database will be of great
importance to experimentalists who wish to examine in detail
their particular proteins of interest. This will also provide
access to the numerous examples that have not been dealt
with here, including exposed functionally relevant phos-
phosites and those that could be silent (nonfunctional)
phosphorylations.
Conclusion
We have implemented a database of phosphorylated residues
that allows straightforward comparison of phosphorylation
patterns obtained from different experiments. In addition,
clues about the molecular effect of phosphorylation on some
proteins domains have been obtained by examining their
structural models stored on the database. It is hoped that the
mtcPTM database will serve as a working tool for
experimentalists, but it should also be a useful resource to
theoretical biologists because it houses a large collection of
protein phosphorylation data. Ultimately, the knowledge
obtained from mining this database will be important to fur-http://genomebiology.com/2007/8/5/R90 Genome Biology 2007,     Volume 8, Issue 5, Article R90       Jiménez et al. R90.17
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ther our understanding of the regulation of protein function
by PTMs. Researchers are encouraged to submit their data for
storage and public display.
Materials and methods
Genomic peptide matching
The genomic matching was performed separately for each set
of peptides from individual experiments. First, the peptides
were compared as strings for perfect matches to Ensembl pro-
teins. Unmatched peptides were then compared against all
Uniprot entries from a given organism [73]. When perfect
matches to Uniprot were found, the matched Uniprot entry
was used to extend the peptide sequences by 10 residues at
both termini. The extended peptides were then BLASTed
against Ensembl proteins [74]. This sequence extension was
important to improve the signal-to-noise ratio of the BLAST
searches, especially for short peptides, and to increase the
chance of identifying the variation that precluded a perfect
match, especially when the variation took place at the ends or
involved insertion/deletions that could have truncated the
reported alignment. Only matches covering the initial, unex-
tended peptides were considered further.
The adequacy of the matches was then assessed by their
length coverage, sequence identity and the existence of previ-
ous perfect matches to the same proteins. The philosophy of
the assessment was initially to weight more favorably high
sequence similarity between genomic regions and experimen-
tally determined peptides, and only to consider low similarity
cases that involved proteins previously matched perfectly by
another peptide from the same experiment. Thus, this assess-
ment had three hierarchical levels of stringency against which
all of the matches for a given peptide were examined until a
match was considered to be adequate. First, if the number of
mismatches was zero and the length covered was at least 85%
of the peptide, or the full-length peptide was matched with a
sequence identity of at least 85%, then the peptide-protein
match was accepted independently on whether there existed
previous matches for that protein. These 85% cut-offs
minimized spurious matches without losing many real ones,
as deduced from a test dataset (data not shown). If no ade-
quate peptide matches were found, then the second assess-
ment would admit matches with values of at least 85% for
both length coverage and sequence identity but only involving
proteins previously identified. In the final and least strict
assignment, protein-peptide matches were accepted if the
protein had previously been identified and the matches had
either 85% length coverage or sequence identity. At present,
the peptide matching procedure does not penalize disagree-
ments between the flanking sequences from the proteins
matched by the peptides with respect to those expected by the
characteristic digestion pattern of the protease employed in
the experiment.
Phosphorylated sites obtained from literature and other
resources were handled in a similar way because they were
actually stored in the database as artificially long peptide
sequences, extracted from their original source entries, with
the modified residues situated at their central position. This
facilitates the complete reassignment of all protein-peptide
matches every time that a new version of Ensembl is released.
Clustering peptide-protein matches from each 
experiment into minimal protein lists
Following the matching of peptides to genes, it was necessary
to analyze further those peptides with multiple matches,
either to more than one protein from a single gene or to pro-
teins from different genes, in order to determine whether the
assignment could be further restricted to a single peptide-
protein or peptide-gene pair, respectively. Thus, after the ini-
tial assignment of every peptide to one or more proteins, the
peptides from an experiment were grouped according to the
matched proteins in order to find a minimal list of proteins
that could explain all of the matches observed [75]. A protein
was regarded as part of the minimal list if at least one of its
peptides was unique or if it represented a unique combination
of peptides that was not a subgroup of the peptide set of
another protein. When the experiment provides high
sequence coverage for each protein, this assignment can be
unambiguous. However, when the sequence coverage is low,
as is sometimes the case for high-throughput data, it can be
difficult to distinguish between splicing variants or cross-
matches. Because of this, even though every matched protein
will eventually be described as being part or not of a minimal
list, the mtcPTM database still keeps all the matches origi-
nally found, which can be visualized online for further critical
inspection (Figure 1).
Structural modeling of protein domains containing 
phosphorylatable residues
Only proteins belonging to the minimal lists were considered
for homology modeling. The feasibility of building models for
these proteins, or for fragments of them, was determined
according to their significant sequence similarity to available
high-resolution structures. The sequence set of determined
structures was obtained from Protein Data Bank (PDB) co-
ordinates [76]. Positions for which no electron density was
available were given the amino acid letter code 'X'. The final
set included a set of redundant sequences containing all the
full-length sequences from PDB structures as well as those of
their individual domains as defined by Structural Classifica-
tion of Proteins (SCOP) [77,78]. This redundancy was neces-
sary because our fold recognition procedure mandated that
the regions matched onto the protein queries should cover the
entire length of the structural units in order to avoid missing
structural elements in the three-dimensional models.
The structural assignment was performed as follows. Each
protein sequence was first BLASTed against the structural
database. Matches were initially considered adequate if theyR90.18 Genome Biology 2007,     Volume 8, Issue 5, Article R90       Jiménez et al. http://genomebiology.com/2007/8/5/R90
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covered 80% of the length of the structural unit sharing no
less than 30% sequence identity. Subsequently, the regions
matched on the protein were extended in both directions to
account for the full-length of the structure, and both
sequences were realigned using ClustalX [79]. The extension/
alignment procedure was iterated until the protein covered
exactly the entire length of the structure. After convergence,
all pair-wise alignments with less than 30% sequence identity
(including gaps) or more than 5% gapped regions in both
sequences were discarded. If two possible models from the
same protein covered exactly the same set of modified resi-
dues, only that with the highest sequence identity to their
structural template was considered. The whole procedure was
automatic and therefore the pair-wise alignments were not
inspected or adjusted manually. However, given the strict
sequence similarity and length coverage cut-offs imposed, it
is likely that most alignments will be correct. The homology
models were built from the pair-wise alignments using MOD-
ELLER with default values [80].
Creating a nonredundant set of structural models
To make a nonredundant set of structural models the
sequences of all the modeled structures were clustered using
BLASTclust with cut-offs of 40% sequence similarity and
80% length coverage. After the clustering, the member with
the highest number of phosphorylated sites (or highest
sequence identity to the template if their number of phos-
phosites was identical) from each group was taken. The
nonredundant set used in the structural analysis (and pro-
vided in the Additional data files) was based on the mtcPTM
release corresponding to Ensembl version 40. Updated ver-
sions of the structural models can be found in the live site.
Additional data files
The following additional data are available with the online
version of the paper. Additional data file 1 provides examples
of phosphosites found at the flanks of structured domains.
Additional data file 2 provides examples of phosphorylatable
buried residues.
Additional data file 1 Examples of phosphosites found at the flanks of structured  domains The table provides further information about the modeling as well  as mtcPTM links for each protein described in Figure 4. For each  entry, the columns represent the corresponding Figure number  (FIGURE), Ensembl identifier (PID), link to mtcPTM (mtcPTM  link), start (Nt) and end (Ct) of the structure with respect to the full- length sequence, PDB template used for the modeling (PDBID) as  well as the pair-wise sequence identity (IDENT), the position of the  phosphosite (RESIDUE), experimental source (EXPERIMENT),  the termini involved (TAIL), and the distance to the structured  domain (DISTANCE). Click here for file Additional data file 2 Examples of phosphorylatable buried residues The table provides further information about the modelling as well  as mtcPTM links for each protein described in Figures 8 to 10. For  each entry, the columns represent the same fields described in  Additional data file 1, along with the addition of two new columns  containing the percentage of solvent accessibility for the whole side  chain (SA-side) or only for its polar atoms (SA-polar). Click here for file
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